Sargent Bickham Lagudis’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$4.15K Buy
+50
New +$4.05K ﹤0.01% 825
2022
Q2
Sell
-100
Closed -$9K 1150
2022
Q1
$9K Hold
100
﹤0.01% 735
2021
Q4
$11K Hold
100
﹤0.01% 704
2021
Q3
$13K Hold
100
﹤0.01% 682
2021
Q2
$14K Hold
100
﹤0.01% 668
2021
Q1
$14K Hold
100
﹤0.01% 645
2020
Q4
$14K Buy
100
+15
+18% +$1.92K ﹤0.01% 614
2020
Q3
$9K Buy
85
+20
+31% +$2.24K ﹤0.01% 614
2020
Q2
$7K Buy
65
+30
+86% +$2.96K ﹤0.01% 619
2020
Q1
$3K Buy
+35
New +$3.1K ﹤0.01% 689
2018
Q4
Sell
-1,647
Closed -$158K 808
2018
Q3
$158K Hold
1,647
0.02% 228
2018
Q2
$157K Hold
1,647
0.02% 228
2018
Q1
$144K Hold
1,647
0.02% 244
2017
Q4
$140K Hold
1,647
0.02% 250
2017
Q3
$143K Hold
1,647
0.02% 248
2017
Q2
$127K Hold
1,647
0.02% 245
2017
Q1
$114K Hold
1,647
0.01% 259
2016
Q4
$97K Hold
1,647
0.02% 266
2016
Q3
$109 Hold
1,647
0.02% 262
2016
Q2
$89K Hold
1,647
0.01% 279
2016
Q1
$85K Buy
+1,647
New +$85.5K 0.01% 291

Other funds holding XBI